Literature DB >> 18577527

Adenovirus-mediated stromal cell-derived- factor-1alpha gene transfer induces cardiac preservation after infarction via angiogenesis of CD133+ stem cells and anti-apoptosis.

Junming Tang1, Jianing Wang, Jianye Yang, Xia Kong.   

Abstract

In our study, we found cardiocytes expressed CXCR4, and the number of cardiocytes apoptosis with SDF-1 treatment decreased obviously through SDF-1 induced the up-regulation of phosphorylated Akt. On day 7 after myocardial infarction, marked expression of SDF-1alpha, and the number of CD133(+) cells was the highest in the AdV-SDF-1 injection hearts. On day 28 post-treatment, blood vessel density in the AdV. SDF-1 group was higher in infracted zones. Infarct size and collagen accumulation in the infracted area decreased significantly, thickness of LV wall, vessels and cardiocytes' density increased obviously in the AdV-SDF-1 group than in control or Adv-LacZ group, and hemodynamics showed the improvement of left ventricle heart function in the AdV.SDF-1 group. Therefore, SDF-1alpha could improve cardiac structure and function through the combined effects of angiogenesis and anti-apoptosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18577527     DOI: 10.1510/icvts.2007.169896

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  9 in total

Review 1.  Drug discovery research targeting the CXC chemokine receptor 4 (CXCR4).

Authors:  Won-Tak Choi; Srinivas Duggineni; Yan Xu; Ziwei Huang; Jing An
Journal:  J Med Chem       Date:  2011-12-02       Impact factor: 7.446

Review 2.  Targeted gene therapy for the treatment of heart failure.

Authors:  Kleopatra Rapti; Antoine H Chaanine; Roger J Hajjar
Journal:  Can J Cardiol       Date:  2011 May-Jun       Impact factor: 5.223

Review 3.  Engineering Stem Cells for Biomedical Applications.

Authors:  Perry T Yin; Edward Han; Ki-Bum Lee
Journal:  Adv Healthc Mater       Date:  2015-03-13       Impact factor: 9.933

4.  Computational protein design to reengineer stromal cell-derived factor-1α generates an effective and translatable angiogenic polypeptide analog.

Authors:  William Hiesinger; Jose Manuel Perez-Aguilar; Pavan Atluri; Nicole A Marotta; John R Frederick; J Raymond Fitzpatrick; Ryan C McCormick; Jeffrey R Muenzer; Elaine C Yang; Rebecca D Levit; Li-Jun Yuan; John W Macarthur; Jeffery G Saven; Y Joseph Woo
Journal:  Circulation       Date:  2011-09-13       Impact factor: 29.690

Review 5.  Re-engineered stromal cell-derived factor-1α and the future of translatable angiogenic polypeptide design.

Authors:  William Hiesinger; Andrew B Goldstone; Y Joseph Woo
Journal:  Trends Cardiovasc Med       Date:  2012-08-16       Impact factor: 6.677

6.  Mesenchymal Stem Cells Drive Cardiac Stem Cell Chemotaxis, Proliferation, and Phenotype via CXCR4 and cKit Signaling.

Authors:  Kenneth Michael Fish
Journal:  Circ Res       Date:  2016-09-30       Impact factor: 17.367

7.  Adenovirus-mediated stromal cell-derived factor-1 alpha gene transfer improves cardiac structure and function after experimental myocardial infarction through angiogenic and antifibrotic actions.

Authors:  Junming Tang; Jianing Wang; Hongxian Song; Yongzhang Huang; Jianye Yang; Xia Kong; Linyun Guo; Fei Zheng; Lei Zhang
Journal:  Mol Biol Rep       Date:  2009-08-04       Impact factor: 2.316

8.  Identification of miR-27b as a novel signature from the mRNA profiles of adipose-derived mesenchymal stem cells involved in the tolerogenic response.

Authors:  Kuang-Den Chen; Shigeru Goto; Li-Wen Hsu; Tzu-Yang Lin; Toshiaki Nakano; Chia-Yun Lai; Yen-Chen Chang; Wei-Teng Weng; Yur-Ren Kuo; Chih-Chi Wang; Yu-Fan Cheng; Yen-Ying Ma; Chih-Che Lin; Chao-Long Chen
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

Review 9.  Nanomedicine for Gene Delivery for the Treatment of Cardiovascular Diseases.

Authors:  Cen Yan; Xiao-Jiang Quan; Ying-Mei Feng
Journal:  Curr Gene Ther       Date:  2019       Impact factor: 4.391

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.